Determining the association between COVID 19 and cancer: An observational study

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. All patients with a cancer diagnosis who develop COVID-19 during the period of March to August 2020. This includes all patients with a proven diagnosis of cancer at any stage of management [under evaluation, those on active treatment (curative or palliative intent) and those on follow-up (short or long-term)]
•2. Controls (for the impact of COVID-19 on cancer sub-study) will include retrospectively-matched patients with cancer who do not have a diagnosis of COVID. Patients will be matched for age, gender, cancer type and stage. We will include 2 groups of patients â?? concurrent (patients with cancer treated during the same time period who did not have a COVID diagnosis) and historical.
•3. Controls for the exploratory sub-study (cytokine and immune response in cancer patients with COVID) are health-care workers diagnosed with COVID

发起方